Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eugene Boyle currently holds 435,000 shares of SAMARITAN PHARMACEUTICALS INC (LIV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eugene Boyle has been a net neutral trader of LIV stock. They have purchased $0 and sold $0 worth of shares.
Eugene Boyle's most recent insider trade was on Sep 11, 2008, when they sold 435,000 shares at $0.20 per share.
Eugene Boyle serves as Executive at SAMARITAN PHARMACEUTICALS INC (LIV). They have executed 8 insider transactions totaling $0 over their tenure at the company.
Eugene Boyle holds the position of Executive at SAMARITAN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Eugene Boyle has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Eugene Boyle was on Jan 4, 2008, when they sold $185.3K worth of LIV shares. This transaction involved 529,361 shares at $0.35 per share.
Eugene Boyle currently owns 435,000 shares of SAMARITAN PHARMACEUTICALS INC (LIV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eugene Boyle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eugene Boyle has 8 Form 4 filings on record as an insider at SAMARITAN PHARMACEUTICALS INC.
Set alerts for Eugene Boyle and 40,000+ other insiders.